Healthtech PR
PR for femtech and women’s-health startups
PR for femtech and women’s-health startups works when you combine a genuinely underserved need with credible evidence and honest, stigma-breaking storytelling. It’s a category the media is hungry to cover well — which rewards founders who bring data, expertise and real user stories rather than hype. Here’s how to earn that coverage.
Why is women’s health such a strong media story right now?
Women’s health has been historically underfunded and under-researched, and journalists, investors and audiences are actively looking for credible voices closing that gap. That appetite is an opportunity: a startup with real data on an overlooked problem can command serious coverage — provided the claims are careful and the tone is respectful.
What angles resonate?
Original data on an under-measured experience (menopause at work, cycle tracking, fertility access), founder stories rooted in a real problem, expert commentary from clinical advisors, and reactive comment on policy or research. Investor-facing coverage (funding milestones, market gaps) builds credibility with a different but valuable audience. It’s the same mix we use in healthtech PR for apps and devices.
What sensitivities must you handle carefully?
Women’s health topics can be intimate and stigmatised; handle them with accuracy and dignity, avoid sensationalism, and be rigorous about medical claims — much of femtech touches regulated territory. Clinical advisors and careful claims aren’t just compliance; they’re what makes serious outlets take you seriously.
Frequently asked questions
Is femtech PR different from general health PR?
It shares the compliance discipline but adds an investor-and-advocacy dimension and requires careful, dignified handling of sensitive topics.
What coverage should a femtech startup target?
A blend of health and national titles for authority, trade and business press for investor credibility, and podcasts for founder storytelling.